Adial Pharmaceuticals
ADIL
14 hedge funds and large institutions have $1.53M invested in Adial Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
40% more funds holding
Funds holding: 10 → 14 (+4)
37% more capital invested
Capital invested by funds: $1.11M → $1.53M (+$418K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$76.4K |
| 2 |
AGM
Alpine Global Management
New York
|
+$56.8K |
| 3 |
VF
Virtu Financial
New York
|
+$27.9K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$17.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$209K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$129K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $459K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $439K | -$129K | -138 | -30% |
|
|
3
Renaissance Technologies
New York
| $207K | +$76.4K | +82 | +122% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $173K | – | – | – |
|
|
AGM
5
Alpine Global Management
New York
| $85K | +$56.8K | +61 | New |
|
6
Brown Advisory
Baltimore,
Maryland
| $58K | – | – | – |
|
|
VF
7
Virtu Financial
New York
| $42K | +$27.9K | +30 | New |
|
|
8
Northern Trust
Chicago,
Illinois
| $27K | +$17.7K | +19 | New |
|
9
Commonwealth Equity Services
Waltham,
Massachusetts
| $23K | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $9K | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $5K | +$3.73K | +4 | New |
|
12
UBS Group
Zurich,
Switzerland
| $3K | +$1.86K | +2 | New |
|
13
Wells Fargo
San Francisco,
California
| $2K | – | – | – |
|
14
Morgan Stanley
New York
| $1K | – | – | – |
|
|
15
Bank of America
Charlotte,
North Carolina
| – | -$209K | -240 | Closed |
|
ADIL Hedge Fund Activity: Q3 2020 in Review
14 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q3 2020, worth a combined $1.53M — up 37% from $1.11M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ADIL positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $76.4K. The largest seller was Bank of America, exiting entirely with an estimated $209K sold.
- 14 institutional investors held Adial Pharmaceuticals (ADIL) as of Q3 2020, up from 10 in Q2 2020.
- Funds reported $1.53M of Adial Pharmaceuticals stock for Q3 2020, up 37% quarter-over-quarter.
- 5 funds opened new Adial Pharmaceuticals positions in Q3 2020 and 1 closed out, a net change of +4 holders.
- The largest Adial Pharmaceuticals buyer in Q3 2020 was Renaissance Technologies, an estimated $76.4K added.
- The largest Adial Pharmaceuticals seller in Q3 2020 was Bank of America, an estimated $209K sold.
Based on aggregated 13F filings for Q3 2020.